(Q45025381)

8 December 2017

Reduction of in vivo binding of [3H]paroxetine in mouse brain by 3,4-methylenedioxymethamphetamine (English)

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

1 November 2022

1

K. Hashimoto

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696701

1 November 2022

author name string

T. Goromaru

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696701

1 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1696701

1 November 2022

publication date

1 July 1990

1 reference

full work available at URL

8 December 2017

https://api.elsevier.com/content/article/PII:002839089090024L?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

https://api.elsevier.com/content/article/PII:002839089090024L?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

1 November 2022

1 reference

8 December 2017

29

1 reference

8 December 2017

7

1 reference

8 December 2017

633-639

1 reference

MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons.

8 December 2017

1

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Centrally active N-substituted analogs of 3,4-methylenedioxyphenylisopropylamine (3,4-methylenedioxyamphetamine)

1 November 2022

3

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

1 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Aminergic systems in Alzheimer's disease and Parkinson's disease.

1 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Stereochemistry of the metabolism of MDMA to MDA.

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Characterization of [3H]paroxetine binding to rat cortical membranes.

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Tryptophan hydroxylase activity and synaptosomal uptake of serotonin in discrete brain regions after midbrain raphe lesions: Correlations with serotonin levels and histochemical fluorescence

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Differences between rats and mice in MDMA (methylenedioxymethylamphetamine) neurotoxicity.

1 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Protein measurement with the Folin phenol reagent

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders.

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Decreased imipramine binding in the brains of patients with depressive illness.

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Parkinson's disease: decreased density of 3H-imipramine and 3H-paroxetine binding sites in putamen.

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

In vivo labeling of serotonin uptake sites with [3H]paroxetine

1 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.

1 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Direct central effects of acute methylenedioxymethamphetamine on serotonergic neurons

1 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

The background and chemistry of MDMA.

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Tritiated imipramine binding sites are decreased in the frontal cortex of suicides.

1 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Differences in the central serotonergic effects of methylenedioxymethamphetamine (MDMA) in mice and rats.

1 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

1 November 2022

27

1 reference

https://api.crossref.org/works/10.1016/0028-3908(90)90024-L

1 November 2022

Identifiers

1 reference

8 December 2017

1 reference